M&A Deal Summary

Premier Biotech Acquires DesertTox

On June 6, 2024, Premier Biotech acquired life science company DesertTox

Acquisition Highlights
  • This is Premier Biotech’s 1st transaction in the Life Science sector.
  • This is Premier Biotech’s 1st transaction in the United States.
  • This is Premier Biotech’s 1st transaction in Arizona.

M&A Deal Summary
Date 2024-06-06
Target DesertTox
Sector Life Science
Buyer(s) Premier Biotech
Deal Type Add-on Acquisition

Target

DesertTox

Scottsdale, Arizona, United States
DesertTox provides certified laboratory testing services for the Substance Abuse and Mental Health Services Administration (“SAMHSA”). The company serves customers throughout the United States across a broad range of end markets, including HHS/DOT, employment, occupational health, and government markets. DesertTox is based in Scottsdale, Arizona.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Premier Biotech

Minneapolis, Minnesota, United States
Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Premier Biotech is a provider of point-of-care and rapid drugs of abuse diagnostic testing devices supported by an accredited laboratory. The Company’s products and corresponding laboratory services are used in the workplace (hiring and safety applications), government (child and family services, criminal justice, corrections and DOT applications) and clinical (medication monitoring) segments. Premier Biotech was founded in 2009 and is based in Minneapolis, Minnesota.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Arizona) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal